Atlas Trials

Elevar Therapeutics

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Elevar Therapeutics

RecordFirmDate
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement (NCT07359820)Elevar Therapeutics2026-06-04
A Study Comparing Four Different Rivoceranib Tablets in Healthy Participants (NCT05287360)Elevar Therapeutics2021-12-30
REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors (NCT04526106)Elevar Therapeutics2020-09-02
A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) (NCT04119453)Elevar Therapeutics2020-01-22
A Study to Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer (NCT03707028)Elevar Therapeutics2018-10-01
A Study to Evaluate Apatinib (Also Known as Rivoceranib) Plus Nivolumab in Participants With Unresectable or Metastatic Cancer (NCT03396211)Elevar Therapeutics2017-12-22

Track Elevar Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.